CML Outcomes and Care Delivery During the COVID-19 Pandemic in Low- and Middle-Income Countries

Author:

Matsuzaki Mika,Annamalay Alicia,Garcia-Gonzalez Pat,Radich Jerald

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology

Reference10 articles.

1. Bower H, Björkholm M, Dickman PW, Höglund M, Lambert PC, Andersson TM-L. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population. J Clin Oncol. 2016;34:2851–7. https://doi.org/10.1200/JCO.2015.66.2866. Analysis of Swedish Cancer Registry in 1973–2013 demonstrating advancement in treatment options for CML has improved the life expectancy of patients with CML to a similar level in the general population.

2. Malhotra H, Radich J, Garcia-Gonzalez P. Meeting the needs of CML patients in resource-poor countries. Hematology 2014, the American Society of Hematology Education Program Book. 2019;2019(1):433–42. https://doi.org/10.1182/hematology.2019000050. A great overview of the myriad challenges and solutions of diagnosing and treating CML in low- and-middle income coutries.

3. Garcia-Gonzalez P, Boultbee P, Epstein D. Novel humanitarian aid program: the glivec international patient assistance program-lessons learned from providing access to breakthrough targeted oncology treatment in low- and middle-income countries. J Glob Oncol. 2015;1(1):37–45. https://doi.org/10.1200/JGO.2015.000570. The article describes the structure of the GIPAP program and lessons that have contributed to the success of the program.

4. The Max Foundation. Patient Access Tracking System. [cited 6 Jun 2022]. Available: https://www.maxaid.org/

5. Bottan N, Hoffmann B, Vera-Cossio D. The unequal impact of the coronavirus pandemic: evidence from seventeen developing countries. PLoS ONE. 2020;15:e0239797. https://doi.org/10.1371/journal.pone.0239797.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3